NLRP3 and Alzheimer disease: The pathological role of microglial NLRP3 in perpetuating AD-related neuroinflammation has been validated in animal models, patient-derived cells [71] and post-mortem brain analyses [33], highlighting this pathway as a potential therapeutic target [73, 80].